magnify
发表于 2025-3-21 19:25:59
书目名称Studies of the Biogeochemistry of Typical Estuaries and Bays in China影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0880963<br><br> <br><br>书目名称Studies of the Biogeochemistry of Typical Estuaries and Bays in China影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0880963<br><br> <br><br>书目名称Studies of the Biogeochemistry of Typical Estuaries and Bays in China网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0880963<br><br> <br><br>书目名称Studies of the Biogeochemistry of Typical Estuaries and Bays in China网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0880963<br><br> <br><br>书目名称Studies of the Biogeochemistry of Typical Estuaries and Bays in China被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0880963<br><br> <br><br>书目名称Studies of the Biogeochemistry of Typical Estuaries and Bays in China被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0880963<br><br> <br><br>书目名称Studies of the Biogeochemistry of Typical Estuaries and Bays in China年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0880963<br><br> <br><br>书目名称Studies of the Biogeochemistry of Typical Estuaries and Bays in China年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0880963<br><br> <br><br>书目名称Studies of the Biogeochemistry of Typical Estuaries and Bays in China读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0880963<br><br> <br><br>书目名称Studies of the Biogeochemistry of Typical Estuaries and Bays in China读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0880963<br><br> <br><br>
肿块
发表于 2025-3-21 21:47:28
http://reply.papertrans.cn/89/8810/880963/880963_2.png
FAST
发表于 2025-3-22 00:37:26
http://reply.papertrans.cn/89/8810/880963/880963_3.png
运动的我
发表于 2025-3-22 05:43:14
http://reply.papertrans.cn/89/8810/880963/880963_4.png
令人不快
发表于 2025-3-22 12:05:05
Zhiliang Shen,Qun Liu,Shumei Zhang,Hui Miao,Ping Zhangpes. Advances in sequencing technologies have demonstrated that diverse genetic CSCs subclones, derived from the branching evolution, compete with each other within the tumor mass, thereby contributing to the functional heterogeneity. It is becoming increasingly clear that epigenetic modifications a
灾难
发表于 2025-3-22 16:54:03
http://reply.papertrans.cn/89/8810/880963/880963_6.png
paradigm
发表于 2025-3-22 19:27:01
http://reply.papertrans.cn/89/8810/880963/880963_7.png
Ambulatory
发表于 2025-3-22 23:04:48
http://reply.papertrans.cn/89/8810/880963/880963_8.png
清唱剧
发表于 2025-3-23 02:53:31
Shaofeng Pei,Zhiliang Shen,Edward A. Lawsn B cell malignancies during the last decade. Ibrutinib, a first-in-class, potent, orally administered covalently-binding inhibitor of BTK was recently approved for the treatment of chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), Waldenström’s macroglobulinemia (WM) and marginal-zone
LEVER
发表于 2025-3-23 09:23:14
Zhiliang Shen cycle deregulation is a hallmark of cancer, and CDKs have long been considered attractive targets for anti-cancer agents. After initial failures of pan-CDKi in clinical trials, two highly specific CDK4/6 inhibitors, palbociclib and ribociclib, are now FDA-approved in hormone receptor-positive breas